YG1702 is a potent ALDH18A1 -specific inhibitor. YG1702 attenuates the growth of MYCN-amplified NB and down-regulates MYCN . YG1702 physically interacts with ALDH18A1 with a high affinity and might potentially affect its enzymatic activity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Aldehyde Dehydrogenase (ALDH)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.